Hypertension, inhibitors of the renin angiotensin system and Covid-19
- Funded by CSO Scotland
- Total publications:1 publications
Grant number: COV/GLA/20/04
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$99,009.04Funder
CSO ScotlandPrincipal Investigator
Rhain TouyzResearch Location
United KingdomLead Research Institution
University of GlasgowResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Prognostic factors for disease severity
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
There is a lot of coverage in the media that certain drugs to treat high blood pressure (hypertension) may worsen COVID-19. However, there is no clinical evidence to support this and there is much confusion for both patients and doctors. Many patients are stopping their hypertension medication, which is dangerous as this could lead to severe heart disease and even death. Our study will examine if hypertensive patients have more severe COVID-19 than patients who do not have pre-existing hypertension. We will also assess if certain blood pressure drugs aggravate or improve infection. This is especially important in Scotland where the rate of hypertension is high. Our study will provide information to guide doctors and patients in the coming months as we treat COVID.
Publicationslinked via Europe PMC
Last Updated:14 hours ago
View all publications at Europe PMC